STOCK TITAN

[Form 4] Concentrix Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Concentrix (CNXC)code F disposition of 1,403 shares of common stock at $46.04. After this transaction, the reporting person directly beneficially owns 41,008 shares. The filer is listed as EVP, Global Sales, Acct Mgmt, and the filing was made by one reporting person.

Concentrix (CNXC) ha riferito una transazione interna da parte di un dirigente. Il 27/10/2025, un Modello 4 mostra una disposizione con codice F di 1.403 azioni ordinarie a $46,04. Dopo questa operazione, la persona che segnala detiene direttamente 41.008 azioni di diritto beneficiario. Il registrante è elencato come EVP, Global Sales, Acct Mgmt, e la dichiarazione è stata presentata da una persona che segnala.

Concentrix (CNXC) informó una operación interna por parte de un directivo. El 27/10/2025, un Formulario 4 muestra una disposición con código F de 1,403 acciones de acciones comunes a $46,04. Después de esta operación, la persona que informa posee directamente 41,008 acciones de forma beneficiosa. El presentante figura como EVP, Global Sales, Acct Mgmt, y la presentación fue realizada por una persona que informa.

콘센트릭스(CNXC)가 임원 1명의 내부 거래를 보고했습니다. 2025년 10월 27일, Form 4는 코드 F의 처분으로 1,403주의 보통주를 $46.04에 매도한 것을 보여줍니다. 이 거래 후, 보고자는 직접적으로 41,008주를 유리하게 보유합니다. 제출자는 EVP, Global Sales, Acct Mgmt로 기재되었으며, 제출은 한 명의 보고자가 수행했습니다.

Concentrix (CNXC) a annoncé une opération interne d'un cadre dirigeant. Le 27/10/2025, un Formulaire 4 indique une cession avec code F de 1 403 actions ordinaires à 46,04 $. Après cette opération, la personne déclarant détient directement 41 008 actions de manière bénéficiaire. Le déclarant est répertorié comme EVP, Global Sales, Acct Mgmt, et le dépôt a été effectué par une seule personne déclarant.

Concentrix (CNXC) meldete eine Insider-Transaktion eines leitenden Angestellten. Am 27.10.2025 zeigt ein Formular 4 eine Veräußerung mit Code F von 1.403 Aktien Stammaktien zu 46,04 $. Nach dieser Transaktion besitzt die meldepflichtige Person direkt 41.008 Aktien benefiational. Der Einreicher ist als EVP, Global Sales, Acct Mgmt aufgeführt, und die Einreichung erfolgte durch eine meldende Person.

Concentrix (CNXC) أبلغت عن صفقة داخلية من قبل مسؤول تنفيذي. في 27/10/2025، يُظهر النموذج 4 تخصيصاً برمز F لــ 1,403 سهمًا من الأسهم العادية بسعر $46.04. بعد هذه الصفقة، يمتلك الشخص المبلغ مباشرةً 41,008 سهمًا بشكل مستفيد. المشرف عليه مدرج كـ EVP, Global Sales, Acct Mgmt، وقد تم تقديم الإبلاغ بواسطة شخص واحد يقدِّم التقرير.

Positive
  • None.
Negative
  • None.

Concentrix (CNXC) ha riferito una transazione interna da parte di un dirigente. Il 27/10/2025, un Modello 4 mostra una disposizione con codice F di 1.403 azioni ordinarie a $46,04. Dopo questa operazione, la persona che segnala detiene direttamente 41.008 azioni di diritto beneficiario. Il registrante è elencato come EVP, Global Sales, Acct Mgmt, e la dichiarazione è stata presentata da una persona che segnala.

Concentrix (CNXC) informó una operación interna por parte de un directivo. El 27/10/2025, un Formulario 4 muestra una disposición con código F de 1,403 acciones de acciones comunes a $46,04. Después de esta operación, la persona que informa posee directamente 41,008 acciones de forma beneficiosa. El presentante figura como EVP, Global Sales, Acct Mgmt, y la presentación fue realizada por una persona que informa.

콘센트릭스(CNXC)가 임원 1명의 내부 거래를 보고했습니다. 2025년 10월 27일, Form 4는 코드 F의 처분으로 1,403주의 보통주를 $46.04에 매도한 것을 보여줍니다. 이 거래 후, 보고자는 직접적으로 41,008주를 유리하게 보유합니다. 제출자는 EVP, Global Sales, Acct Mgmt로 기재되었으며, 제출은 한 명의 보고자가 수행했습니다.

Concentrix (CNXC) a annoncé une opération interne d'un cadre dirigeant. Le 27/10/2025, un Formulaire 4 indique une cession avec code F de 1 403 actions ordinaires à 46,04 $. Après cette opération, la personne déclarant détient directement 41 008 actions de manière bénéficiaire. Le déclarant est répertorié comme EVP, Global Sales, Acct Mgmt, et le dépôt a été effectué par une seule personne déclarant.

Concentrix (CNXC) meldete eine Insider-Transaktion eines leitenden Angestellten. Am 27.10.2025 zeigt ein Formular 4 eine Veräußerung mit Code F von 1.403 Aktien Stammaktien zu 46,04 $. Nach dieser Transaktion besitzt die meldepflichtige Person direkt 41.008 Aktien benefiational. Der Einreicher ist als EVP, Global Sales, Acct Mgmt aufgeführt, und die Einreichung erfolgte durch eine meldende Person.

Concentrix (CNXC) أبلغت عن صفقة داخلية من قبل مسؤول تنفيذي. في 27/10/2025، يُظهر النموذج 4 تخصيصاً برمز F لــ 1,403 سهمًا من الأسهم العادية بسعر $46.04. بعد هذه الصفقة، يمتلك الشخص المبلغ مباشرةً 41,008 سهمًا بشكل مستفيد. المشرف عليه مدرج كـ EVP, Global Sales, Acct Mgmt، وقد تم تقديم الإبلاغ بواسطة شخص واحد يقدِّم التقرير.

Concentrix (CNXC) 报告了一项由高管执行的内部交易。2025年10月27日,Form 4 显示以 F 代码 处置 1,403 股 普通股,价格为 $46.04。交易后,报告人直接受益地拥有 41,008 股。披露人被列为 EVP, Global Sales, Acct Mgmt,此次申报由一位报告人完成。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gibson Craig

(Last) (First) (Middle)
39899 BALENTINE DRIVE
SUITE 235

(Street)
NEWARK CA 94560

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Global Sales, Acct Mgmt
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/27/2025 F 1,403 D $46.04 41,008 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Andrew A. Farwig, Attorney-in-Fact 10/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Concentrix

NASDAQ:CNXC

CNXC Rankings

CNXC Latest News

CNXC Latest SEC Filings

CNXC Stock Data

2.66B
52.38M
15.73%
96.77%
11.15%
Information Technology Services
Services-business Services, Nec
Link
United States
NEWARK